|
|
 |
ASCORBIC ACID Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
AMVUTTRA Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
AIRSUPRA Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
RHOPRESSA Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
AMONDYS 45 Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|